<div id="readability-page-1"><p>Arrowstreet Capital Limited Partnership boosted its position in shares of  TriMas Corporation (NASDAQ:TRS - Free Report) by 197.5% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor  owned 249,929 shares of the industrial products company's stock after purchasing an additional 165,925 shares during the quarter. Arrowstreet Capital Limited Partnership owned approximately 0.61% of TriMas worth $7,150,000 at the end of the most recent reporting period.</p><p>Other institutional investors and hedge funds have also recently bought and sold shares of the company. AE Wealth Management LLC purchased a new position in  TriMas in the 2nd quarter valued at about $212,000.  Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in  TriMas during the second quarter valued at about $230,000.  Apexium Financial LP acquired a new stake in  TriMas during the second quarter worth about $243,000.  Teacher Retirement System of Texas acquired a new stake in shares of  TriMas in the second quarter worth $292,000.  Finally, Comerica Bank boosted its position in shares of  TriMas by 214.5% in the first quarter. Comerica Bank now owns 11,119 shares of the industrial products company's stock worth $261,000 after buying an additional 7,584 shares during the period. Hedge funds and other institutional investors own  99.42% of the company's stock. </p><h2>TriMas Stock Up 0.4%</h2><p>Shares of TRS opened at $33.90 on Thursday. The business's 50 day simple moving average is $34.81 and its 200-day simple moving average is $33.71. The company has a debt-to-equity ratio of 0.56, a current ratio of 2.68 and a quick ratio of 1.42. The company has a market capitalization of $1.38 billion, a P/E ratio of 31.39 and a beta of 0.62. TriMas Corporation has a one year low of $19.33 and a one year high of $40.34. </p><p>TriMas (NASDAQ:TRS - Get Free Report) last posted its quarterly earnings data on Tuesday, October 28th. The industrial products company reported $0.61 earnings per share for the quarter, topping the consensus estimate of $0.57 by $0.04. TriMas had a net margin of 4.35% and a return on equity of 12.39%. The firm had revenue of $269.26 million during the quarter, compared to analysts' expectations of $262.05 million. During the same quarter in the previous year, the company posted $0.43 EPS. TriMas's revenue was up 17.4% on a year-over-year basis. TriMas has set its FY 2025 guidance at 2.020-2.120 EPS.  As a group, sell-side analysts predict that  TriMas Corporation will post 1.69 EPS for the current fiscal year. </p><h2>TriMas Dividend Announcement</h2><p>The company also recently declared a quarterly dividend, which was paid on Thursday, November 13th. Stockholders of record on Thursday, November 6th were issued a $0.04 dividend. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date was Thursday, November 6th. TriMas's payout ratio is 14.81%. </p><h2>Wall Street Analyst Weigh In</h2><p>A number of research analysts recently commented on TRS shares. Weiss Ratings  reissued a &#34;hold (c+)&#34; rating on shares of TriMas in a report on Monday. Wall Street Zen cut shares of TriMas from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a report on Saturday, December 6th. Zacks Research upgraded shares of TriMas from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a research report on Friday, August 29th. BWS Financial  reiterated a &#34;buy&#34; rating and issued a $45.00 price objective on shares of TriMas in a report on Friday, December 5th. Finally, KeyCorp decreased their target price on shares of TriMas from $45.00 to $38.00 and set an &#34;overweight&#34; rating for the company in a report on Thursday, November 13th. One equities research analyst  has rated the stock with a Strong Buy rating, two have assigned  a Buy rating and one  has assigned  a Hold rating to the stock. Based on data from MarketBeat.com, the stock  has an average rating of &#34;Buy&#34; and an average price target of $41.50.</p><p><b>Get Our Latest Report on TRS</b></p><h2>Insider Buying and Selling</h2><p>In related news, Director Jeffrey A. Fielkow acquired 2,000 shares of the company's stock in a transaction dated Tuesday, November 11th. The shares were bought at an average price of $31.46 per share, for a total transaction of $62,920.00. Following the purchase, the director directly owned 17,653 shares in the company, valued at approximately $555,363.38. This trade represents a 12.78% increase in their position. The transaction was disclosed in a document filed with the Securities &amp; Exchange Commission, which can be accessed through this link. Insiders own  14.20% of the company's stock. </p><h2>About TriMas</h2> (Free Report)<p>TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba &amp; Ferrari, Intertech, Omega, and Rapak brands.</p><h2>Further Reading</h2><ul><li>Five stocks we like better than TriMas</li><li>What is the Hang Seng index?  </li><li>Market Momentum: 3 Stocks Poised for Major Breakouts</li><li>What is a buyback in stocks? A comprehensive guide for investors</li><li>3 Reasons Casey’s General Stores Will Continue Trending Higher</li><li>What is Forex and How Does it Work? </li><li>Golden Cross Alert: 3 Stocks With Major Upside Potential</li></ul><p><strong>Want to see what other hedge funds are holding TRS?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for TriMas Corporation (NASDAQ:TRS - Free Report).</p><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9VFJT?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9VFJT"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in TriMas Right Now?</h2><p>Before you consider TriMas, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TriMas wasn't on the list.</p><p>While TriMas currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Arrowstreet Capital Limited Partnership increased its stake in TriMas Corporation by 197.5% in Q2, owning 249,929 shares worth $7.15 million. Other institutional investors also acquired shares. TriMas reported Q3 earnings of $0.61 per share, beating estimates, with revenue up 17.4% year-over-year. The company declared a quarterly dividend of $0.04 per share. Analysts have mixed ratings on TRS, with an average price target of $41.50. Insider Jeffrey Fielkow purchased 2,000 shares. TriMas has a market cap of $1.38 billion and a P/E ratio of 31.39.</p>

TriMas Corporation $TRS Shares Purchased by Arrowstreet Capital Limited Partnership